by GlobeNewsWire | Aug 4, 2016 | Canadian Stocks, Globe Newswire
VANCOUVER, British Columbia, Aug. 04, 2016 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewsWire | Aug 1, 2016 | Canadian Stocks, Globe Newswire
VANCOUVER, British Columbia, Aug. 01, 2016 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewsWire | May 10, 2016 | Globe Newswire
VANCOUVER, British Columbia, May 10, 2016 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewsWire | Mar 8, 2016 | Globe Newswire
VANCOUVER, British Columbia, March 08, 2016 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewswireCanada | Dec 22, 2015 | Globe Newswire Canada
VANCOUVER, British Columbia, Dec. 22, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...